Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects-Reference-Cited by-同舟云学术

Empagliflozin Limits Myocardial Infarction in Vivo and Cell Death in Vitro: Role of STAT3, Mitochondria, and Redox Aspects

Published:2017-12-19 Issue: Volume:8 Page:
ISSN:1664-042X
Container-title:Frontiers in Physiology
language:
Short-container-title:Front. Physiol.

Author:

Andreadou Ioanna,Efentakis Panagiotis,Balafas Evangelos,Togliatto Gabriele,Davos Constantinos H.,Varela Aimilia,Dimitriou Constantinos A.,Nikolaou Panagiota-Efstathia,Maratou Eirini,Lambadiari Vaia,Ikonomidis Ignatios,Kostomitsopoulos Nikolaos,Brizzi Maria F.,Dimitriadis George,Iliodromitis Efstathios K.

Publisher

Frontiers Media SA

Subject

Physiology (medical),Physiology

Reference37 articles.

1. Transient carotid ischemia as a remote conditioning stimulus for myocardial protection in anesthetized rabbits: insights into intracellular signaling;Andreadou;Int. J. Cardiol.,2015

2. Short-term statin administration in hypercholesterolemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase and nitro-oxidative stress;Andreadou;Cardiovasc. Res,2012

3. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress;Andreadou;Free Radic. Biol. Med.,2004

4. Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits;Baartscheer;Diabetologia,2017

5. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT;Baldanzi;J. Cell Biol.,2002

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective potential of oleuropein, hydroxytyrosol, oleocanthal and their combination: Unravelling complementary effects on acute myocardial infarction and metabolic syndrome;Redox Biology;2024-10

2. Effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on N-terminal pro-B-type natriuretic peptide (NT-proBNP) level and structural changes following myocardial infarction: A systematic review and meta-analysis;International Journal of Cardiology;2024-09

3. The benefits of oral glucose-lowering agents: GLP-1 receptor agonists, DPP-4 and SGLT-2 inhibitors on myocardial ischaemia/reperfusion injury;European Journal of Pharmacology;2024-08

4. Empagliflozin in Acute Myocardial Infarction Reduces No-Reflow and Preserves Cardiac Function by Preventing Endothelial Damage;JACC: Basic to Translational Science;2024-08

5. Effects of dapagliflozin on myoglobin efflux from cardiomyocyte during myocardial ischemia/reperfusion in anesthetized rats;Scientific Reports;2024-07-16